1. Home
  2. BSRR vs RGNX Comparison

BSRR vs RGNX Comparison

Compare BSRR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$40.66

Market Cap

479.7M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.97

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
RGNX
Founded
1977
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
528.6M
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
BSRR
RGNX
Price
$40.66
$9.97
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$37.00
$28.75
AVG Volume (30 Days)
50.4K
1.9M
Earning Date
04-27-2026
05-05-2026
Dividend Yield
2.93%
N/A
EPS Growth
10.28
18.08
EPS
0.96
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$11.74
$51.21
Revenue Next Year
$3.63
$19.08
P/E Ratio
$42.24
N/A
Revenue Growth
N/A
126.48
52 Week Low
$26.49
$5.46
52 Week High
$41.22
$16.19

Technical Indicators

Market Signals
Indicator
BSRR
RGNX
Relative Strength Index (RSI) 63.41 71.08
Support Level $32.33 $9.51
Resistance Level $41.22 $11.00
Average True Range (ATR) 1.69 0.78
MACD -0.01 0.48
Stochastic Oscillator 86.74 80.39

Price Performance

Historical Comparison
BSRR
RGNX

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: